Ditchcarbon
  • Contact
  1. Organizations
  2. Precigen, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Precigen, Inc. Sustainability Profile

Company website

Precigen, Inc., a pioneering biotechnology company headquartered in the United States, focuses on advancing gene and cell therapies to address significant unmet medical needs. Founded in 2013, Precigen has rapidly established itself in the biopharmaceutical industry, particularly in the fields of immuno-oncology and genetic medicine. The company is renowned for its innovative platforms, including UltraCAR-T™ and AdenoVerse™, which enable the development of unique therapies designed to enhance patient outcomes. With a commitment to transforming healthcare, Precigen has achieved notable milestones, including strategic partnerships and advancements in clinical trials. Positioned as a leader in the biotechnology sector, Precigen continues to push the boundaries of science, striving to deliver cutting-edge solutions that redefine treatment paradigms and improve the lives of patients worldwide.

DitchCarbon Score

How does Precigen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Precigen, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Precigen, Inc.'s reported carbon emissions

Precigen, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Precigen may not have established formal commitments to reduce its carbon footprint or may not be publicly disclosing such information at this time. As a result, the company's climate strategy and initiatives remain unclear within the context of industry standards for emissions reporting and reduction.

How Carbon Intensive is Precigen, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Precigen, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Precigen, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Precigen, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Precigen, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Precigen, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Precigen, Inc.'s Emissions with Industry Peers

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Generation Bio Co.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Promega

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

CureVac

DE
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Autolus Therapeutics plc

GB
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Incyte

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251105.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy